Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study
Withdrawn
- Conditions
- Cholangiocarcinoma
- Registration Number
- NCT00604266
- Lead Sponsor
- University of Toronto
- Brief Summary
To evaluate the feasibility and performance of coregistered 18F-FDG-PET/MRI in the staging of potentially respectable hilar cholangiocarcinoma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Hilar cholangiocarcinoma assessed by conventional imaging modalities (triphasic CT scan of the liver) and thought to be potentially resectable.
Read More
Exclusion Criteria
- Biliary drain inserted.
- Contraindication for MRI.
- Pregnant or breast-feeding.
- Uncontrolled diabetes (over 9.7 mmol/L).
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
UHN - Princess Margaret Hospital
🇨🇦Toronto, Ontario, Canada